{"info": {"doi": "10.1038/nature11003", "link": "https://doi.org/10.1038/nature11003", "title": "The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity", "publisher": "Nature", "date": "2012-03-27 14:44:54", "cited": "1425", "author": "JordiBarretina,GiordanoCaponigro,NicolasStransky,KavithaVenkatesan,Adam A.Margolin,SungjoonKim,Christopher J.Wilson,JosephLehár,Gregory V.Kryukov,DmitriySonkin,AnupamaReddy,ManwayLiu,LaurenMurray,Michael F.Berger,John E.Monahan,PaulaMorais,JodiMeltzer,AdamKorejwa,JuditJané-Valbuena,Felipa A.Mapa,JosephThibault,EvaBric-Furlong,PichaiRaman,AaronShipway,Ingo H.Engels,JillCheng,Guoying K.Yu,JianjunYu,PeterAspesi,Melaniede Silva,KalpanaJagtap,Michael D.Jones,LiWang,CharlesHatton,EmanuelePalescandolo,SupriyaGupta,ScottMahan,CarrieSougnez,Robert C.Onofrio,TedLiefeld,LauraMacConaill,WendyWinckler,MichaelReich,NanxinLi,Jill P.Mesirov,Stacey B.Gabriel,GadGetz,KristinArdlie,VivienChan,Vic E.Myer,Barbara L.Weber,JeffPorter,MarkusWarmuth,PeterFinan,Jennifer L.Harris,MatthewMeyerson,Todd R.Golub,Michael P.Morrissey,William R.Sellers,RobertSchlegel,Levi A.Garraway", "subject": "Multidisciplinary"}, "summary": {"1998": {"cited": 1, "total": 11}, "1999": {"cited": 1, "total": 12}, "2000": {"cited": 0, "total": 12}, "2001": {"cited": 0, "total": 12}, "2002": {"cited": 0, "total": 12}, "2003": {"cited": 1, "total": 13}, "2004": {"cited": 1, "total": 14}, "2005": {"cited": 1, "total": 15}, "2006": {"cited": 0, "total": 15}, "2007": {"cited": 1, "total": 16}, "2008": {"cited": 1, "total": 17}, "2009": {"cited": 0, "total": 17}, "2010": {"cited": 1, "total": 18}, "2011": {"cited": 2, "total": 20}, "2012": {"cited": 100, "total": 120}, "2013": {"cited": 298, "total": 418}, "2014": {"cited": 340, "total": 758}, "2015": {"cited": 397, "total": 1155}, "2016": {"cited": 342, "total": 1497}, "2017": {"cited": 207, "total": 1704}}, "details": {"0": {"title": "The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity", "year": "2012", "cited": "1742", "info": "J Barretina，G Caponigro，N Stransky，... - 《Nature》"}, "1": {"title": "Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.", "year": "2013", "cited": "1369", "info": "J Gao，BA Aksoy，U Dogrusoz，... - 《Science Signaling》"}, "2": {"title": "The landscape of cancer genes and mutational processes in breast cancer.", "year": "2012", "cited": "1005", "info": "PJ Stephens，PS Tarpey，H Davies，... - 《Nature》"}, "3": {"title": "Cancer epigenetics: from mechanism to therapy.", "year": "2012", "cited": "923", "info": "MA Dawson，T Kouzarides - 《Cell》"}, "4": {"title": "Sequence analysis of mutations and translocations across breast cancer subtypes", "year": "2012", "cited": "784", "info": "S Banerji，K Cibulskis，C Rangelescareno，... - 《Nature》"}, "5": {"title": "Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.", "year": "2012", "cited": "764", "info": "M Imielinski，AH Berger，PS Hammerman，... - 《Cell》"}, "6": {"title": "MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer", "year": "2014", "cited": "728", "info": "T Powles，JP Eder，GD Fine，... - 《Nature》"}, "7": {"title": "Mitochondria: in sickness and in health.", "year": "2012", "cited": "613", "info": "J Nunnari，A Suomalainen - 《Cell》"}, "8": {"title": "A transforming KIF5B and RET gene fusion in lungadenocarcinoma revealed from whole- genome and transcriptome sequencing", "year": "2012", "cited": "511", "info": "YS Ju，WC Lee，JS Seo - Genome research"}, "9": {"title": "Mass-spectrometry-based draft of the human proteome.", "year": "2014", "cited": "494", "info": "M Wilhelm，J Schlegl，H Hahne，... - 《Nature》"}, "10": {"title": "Pathways and therapeutic targets in melanoma.", "year": "2014", "cited": "484", "info": "E Shtivelman，MQ Davies，P Hwu，... - 《Oncotarget》"}, "11": {"title": "Garraway LA: Highly recurrent TERT promoter mutations in human melanoma", "year": "2013", "cited": "417", "info": "FW Huang，E Hodis，MJ Xu，..."}, "12": {"title": "Development and validation of a clinical cancer genomic profiling test based on massive parallel DNA sequencing", "year": "2013", "cited": "415", "info": "GM Frampton，A Fichtenholtz，GA Otto，... - 《Nature Biotechnology》"}, "13": {"title": "Cancer Genetics and Epigenetics: Two Sides of the Same Coin?", "year": "2012", "cited": "394", "info": "JS You，PA Jones - 《Cancer Cell》"}, "14": {"title": "The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations", "year": "2012", "cited": "362", "info": "KS Yan，LA Chia，X Li，... - 《Proceedings of the National Academy of Sciences of the United States of America》"}, "15": {"title": "MDM2, MDMX and p53 in oncogenesis and cancer therapy.", "year": "2013", "cited": "336", "info": "M Wade，YC Li，GM Wahl - 《Nature Reviews Cancer》"}, "16": {"title": "Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial", "year": "2014", "cited": "320", "info": "H Wilke，K Muro，CE Van，... - 《Lancet Oncology》"}, "17": {"title": "Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing", "year": "2012", "cited": "320", "info": "P Liu，C Morrison，L Wang，... - 《Carcinogenesis》"}, "18": {"title": "Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool", "year": "2013", "cited": "316", "info": "EY Chen，CM Tan，Y Kou，... - 《Bmc Bioinformatics》"}, "19": {"title": "A colorectal cancer classification system that associates cellular phenotype and responses to therapy", "year": "2013", "cited": "296", "info": "A Sadanandam，CA Lyssiotis，K Homicsko，... - 《Nature Medicine》"}, "20": {"title": "Evaluating cell lines as tumour models by comparison of genomic profiles.", "year": "2013", "cited": "275", "info": "S Domcke，R Sinha，DA Levine，... - 《Nature Communications》"}, "21": {"title": "Combinatorial drug therapy for cancer in the post-genomic era", "year": "2012", "cited": "268", "info": "B Allazikani，U Banerji，P Workman - 《Nature Biotechnology》"}, "22": {"title": "Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis", "year": "2014", "cited": "268", "info": "N Aceto，A Bardia，DT Miyamoto，... - 《Cell》"}, "23": {"title": "EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent", "year": "2012", "cited": "258", "info": "K Xu，ZJ Wu，AC Groner，... - 《Science》"}, "24": {"title": "Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with me...", "year": "2012", "cited": "247", "info": "AJ van，J Versluis，HP van，... - 《Lancet Oncology》"}, "25": {"title": "Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors", "year": "2013", "cited": "241", "info": "EA Akbay，S Koyama，J Carretero，... - 《Cancer Discovery》"}, "26": {"title": "Proteogenomic characterization of human colon and rectal cancer", "year": "2014", "cited": "235", "info": "B Zhang，J Wang，X Wang，... - 《Nature》"}, "27": {"title": "Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions", "year": "2013", "cited": "230", "info": "SEMF De，X Wang，M Jansen，... - 《Nature Medicine》"}, "28": {"title": "THE HISTONE DEACETYLASE SIRT6 IS A NOVEL TUMOR SUPPRESSOR THAT CONTROLS CANCER METABOLISM", "year": "2012", "cited": "227", "info": "C Sebastián，BM Zwaans，DM Silberman，... - 《Cell》"}, "29": {"title": "Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells", "year": "2013", "cited": "219", "info": "W Yang，J Soares，P Greninger，... - 《Nucleic Acids Research》"}, "30": {"title": "β-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis", "year": "2012", "cited": "215", "info": "J Rosenbluh，D Nijhawan，AG Cox，... - 《Cell》"}, "31": {"title": "Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes.", "year": "2012", "cited": "195", "info": "S Sekiya，A Suzuki - 《Journal of Clinical Investigation》"}, "32": {"title": "Targeting epigenetic readers in cancer.", "year": "2012", "cited": "187", "info": "MA Dawson，T Kouzarides，BJ Huntly - 《New England Journal of Medicine》"}, "33": {"title": "Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology", "year": "2013", "cited": "185", "info": "JD Patel，L Krilov，S Adams，... - 《Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology》"}, "34": {"title": "Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance", "year": "2012", "cited": "168", "info": "JA Mccubrey，LS Steelman，WH Chappell，... - 《Oncotarget》"}, "35": {"title": "BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia", "year": "2012", "cited": "166", "info": "CJ Ott，N Kopp，L Bird，... - 《Blood》"}, "36": {"title": "Interpreting noncoding genetic variation in complex traits and human disease", "year": "2012", "cited": "165", "info": "LD Ward，M Kellis - 《Nature Biotechnology》"}, "37": {"title": "Calcium", "year": "Unknown", "cited": "162", "info": " - 《Aid》"}, "38": {"title": "Targeting MYCN in neuroblastoma by BET bromodomain inhibition", "year": "2013", "cited": "154", "info": "A Puissant，SM Frumm，G Alexe，... - 《Cancer Discovery》"}, "39": {"title": "Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers", "year": "2013", "cited": "153", "info": "VW Lui，ML Hedberg，H Li，... - 《Cancer Discovery》"}, "40": {"title": "Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides", "year": "2014", "cited": "151", "info": "K Birsoy，R Possemato，FK Lorbeer，... - 《Nature》"}, "41": {"title": "Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential", "year": "2015", "cited": "148", "info": "P Sharma，JP Allison - 《Cell》"}, "42": {"title": "PGC1α Expression Defines a Subset of Human Melanoma Tumors with Increased Mitochondrial Capacity and Resistance to Oxidative Stress", "year": "2013", "cited": "144", "info": "F Vazquez，JH Lim，H Chim，... - 《Cancer Cell》"}, "43": {"title": "Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice", "year": "2012", "cited": "141", "info": "A Villanueva，C Alsinet，K Yanger，... - 《Gastroenterology》"}, "44": {"title": "Mitochondrial growth and division during the cell cycle in HeLa cells", "year": "1977", "cited": "129", "info": "JW Posakony，JM England，G Attardi - 《Journal of Cell Biology》"}, "45": {"title": "Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib.", "year": "2014", "cited": "128", "info": "N Wagle，BC Grabiner，EM Van Allen，... - 《Cancer Discovery》"}, "46": {"title": "Molecular aspects of cancer cell resistance to chemotherapy.", "year": "2013", "cited": "125", "info": "M Rebucci，C Michiels - 《Biochemical Pharmacology》"}, "47": {"title": "Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICA...", "year": "2014", "cited": "124", "info": "F André，T Bachelot，F Commo，... - 《Lancet Oncology》"}, "48": {"title": "Target Identification for Small Bioactive Molecules: Finding the Needle in the Haystack", "year": "2013", "cited": "124", "info": "S Ziegler，V Pries，C Hedberg，... - 《Angewandte Chemie International Edition》"}, "49": {"title": "Identification and characterization of essential genes in the human genome", "year": "2015", "cited": "124", "info": "T Wang，K Birsoy，NW Hughes，... - 《Science》"}}}